カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ミルベマイシンオキシムの世界市場見通し2023年-2029年

◆英語タイトル：Milbemycin Oxime Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5775）

◆商品コード：MMG23JU5775
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：73
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Milbemycin Oxime Market 調査レポートは次の情報を含め、グローバルにおけるのミルベマイシンオキシム市場規模と予測を収録しています。・世界のミルベマイシンオキシム市場：売上、2018年-2023年、2024年-2029年
・世界のミルベマイシンオキシム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のミルベマイシンオキシム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「小売薬局」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ミルベマイシンオキシムのグローバル主要企業は、Boehringer-Ingelheim、 Virbac、 Ceva、 Krka、 Elanco、 Novartis、 Purinaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ミルベマイシンオキシムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のミルベマイシンオキシム市場：タイプ別、2018年-2023年、2024年-2029年
世界のミルベマイシンオキシム市場：タイプ別市場シェア、2022年
・小売薬局、病院薬局、その他

世界のミルベマイシンオキシム市場：用途別、2018年-2023年、2024年-2029年
世界のミルベマイシンオキシム市場：用途別市場シェア、2022年
・小売薬局、病院薬局、その他

世界のミルベマイシンオキシム市場：地域・国別、2018年-2023年、2024年-2029年
世界のミルベマイシンオキシム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるミルベマイシンオキシムのグローバル売上、2018年-2023年
・主要企業におけるミルベマイシンオキシムのグローバル売上シェア、2022年
・主要企業におけるミルベマイシンオキシムのグローバル販売量、2018年-2023年
・主要企業におけるミルベマイシンオキシムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Boehringer-Ingelheim、 Virbac、 Ceva、 Krka、 Elanco、 Novartis、 Purina

*************************************************************

・調査・分析レポートの概要
ミルベマイシンオキシム市場の定義
市場セグメント
世界のミルベマイシンオキシム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のミルベマイシンオキシム市場規模
世界のミルベマイシンオキシム市場規模：2022年 VS 2029年
世界のミルベマイシンオキシム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのミルベマイシンオキシムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のミルベマイシンオキシム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：小売薬局、病院薬局、その他
ミルベマイシンオキシムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：小売薬局、病院薬局、その他
ミルベマイシンオキシムの用途別グローバル売上・予測

・地域別市場分析
地域別ミルベマイシンオキシム市場規模 2022年と2029年
地域別ミルベマイシンオキシム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Boehringer-Ingelheim、 Virbac、 Ceva、 Krka、 Elanco、 Novartis、 Purina
...

Used in dogs to treat fleas and clams, and to prevent heartworm disease/or treat the following types of intestinal nematode infections: roundworms (canis roundworms and Leonina toxoplasma), hookworms (canine hookworms) and whipworms (vulvar whipworms) ).
This report aims to provide a comprehensive presentation of the global market for Milbemycin Oxime, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Milbemycin Oxime. This report contains market size and forecasts of Milbemycin Oxime in global, including the following market information:
Global Milbemycin Oxime Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Milbemycin Oxime Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Milbemycin Oxime companies in 2022 (%)
The global Milbemycin Oxime market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
125mg/tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Milbemycin Oxime include Boehringer-Ingelheim, Virbac, Ceva, Krka, Elanco, Novartis and Purina, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Milbemycin Oxime manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Milbemycin Oxime Market, by Dose, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Milbemycin Oxime Market Segment Percentages, by Dose, 2022 (%)
125mg/tablet
625mg/tablet
Global Milbemycin Oxime Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Milbemycin Oxime Market Segment Percentages, by Application, 2022 (%)
Retail Pharmacy
Hospital Pharmacy
Others
Global Milbemycin Oxime Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Milbemycin Oxime Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Milbemycin Oxime revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Milbemycin Oxime revenues share in global market, 2022 (%)
Key companies Milbemycin Oxime sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Milbemycin Oxime sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer-Ingelheim
Virbac
Ceva
Krka
Elanco
Novartis
Purina
Outline of Major Chapters:
Chapter 1: Introduces the definition of Milbemycin Oxime, market overview.
Chapter 2: Global Milbemycin Oxime market size in revenue and volume.
Chapter 3: Detailed analysis of Milbemycin Oxime manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by dose, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Milbemycin Oxime in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Milbemycin Oxime capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Milbemycin Oxime Market Definition
1.2 Market Segments
1.2.1 Market by Dose
1.2.2 Market by Application
1.3 Global Milbemycin Oxime Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Milbemycin Oxime Overall Market Size
2.1 Global Milbemycin Oxime Market Size: 2022 VS 2029
2.2 Global Milbemycin Oxime Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Milbemycin Oxime Sales: 2018-2029
3 Company Landscape
3.1 Top Milbemycin Oxime Players in Global Market
3.2 Top Global Milbemycin Oxime Companies Ranked by Revenue
3.3 Global Milbemycin Oxime Revenue by Companies
3.4 Global Milbemycin Oxime Sales by Companies
3.5 Global Milbemycin Oxime Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Milbemycin Oxime Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Milbemycin Oxime Product Type
3.8 Tier 1, Tier 2 and Tier 3 Milbemycin Oxime Players in Global Market
3.8.1 List of Global Tier 1 Milbemycin Oxime Companies
3.8.2 List of Global Tier 2 and Tier 3 Milbemycin Oxime Companies
4 Sights by Product
4.1 Overview
4.1.1 By Dose – Global Milbemycin Oxime Market Size Markets, 2022 & 2029
4.1.2 125mg/tablet
4.1.3 625mg/tablet
4.2 By Dose – Global Milbemycin Oxime Revenue & Forecasts
4.2.1 By Dose – Global Milbemycin Oxime Revenue, 2018-2023
4.2.2 By Dose – Global Milbemycin Oxime Revenue, 2024-2029
4.2.3 By Dose – Global Milbemycin Oxime Revenue Market Share, 2018-2029
4.3 By Dose – Global Milbemycin Oxime Sales & Forecasts
4.3.1 By Dose – Global Milbemycin Oxime Sales, 2018-2023
4.3.2 By Dose – Global Milbemycin Oxime Sales, 2024-2029
4.3.3 By Dose – Global Milbemycin Oxime Sales Market Share, 2018-2029
4.4 By Dose – Global Milbemycin Oxime Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Milbemycin Oxime Market Size, 2022 & 2029
5.1.2 Retail Pharmacy
5.1.3 Hospital Pharmacy
5.1.4 Others
5.2 By Application – Global Milbemycin Oxime Revenue & Forecasts
5.2.1 By Application – Global Milbemycin Oxime Revenue, 2018-2023
5.2.2 By Application – Global Milbemycin Oxime Revenue, 2024-2029
5.2.3 By Application – Global Milbemycin Oxime Revenue Market Share, 2018-2029
5.3 By Application – Global Milbemycin Oxime Sales & Forecasts
5.3.1 By Application – Global Milbemycin Oxime Sales, 2018-2023
5.3.2 By Application – Global Milbemycin Oxime Sales, 2024-2029
5.3.3 By Application – Global Milbemycin Oxime Sales Market Share, 2018-2029
5.4 By Application – Global Milbemycin Oxime Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Milbemycin Oxime Market Size, 2022 & 2029
6.2 By Region – Global Milbemycin Oxime Revenue & Forecasts
6.2.1 By Region – Global Milbemycin Oxime Revenue, 2018-2023
6.2.2 By Region – Global Milbemycin Oxime Revenue, 2024-2029
6.2.3 By Region – Global Milbemycin Oxime Revenue Market Share, 2018-2029
6.3 By Region – Global Milbemycin Oxime Sales & Forecasts
6.3.1 By Region – Global Milbemycin Oxime Sales, 2018-2023
6.3.2 By Region – Global Milbemycin Oxime Sales, 2024-2029
6.3.3 By Region – Global Milbemycin Oxime Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Milbemycin Oxime Revenue, 2018-2029
6.4.2 By Country – North America Milbemycin Oxime Sales, 2018-2029
6.4.3 US Milbemycin Oxime Market Size, 2018-2029
6.4.4 Canada Milbemycin Oxime Market Size, 2018-2029
6.4.5 Mexico Milbemycin Oxime Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Milbemycin Oxime Revenue, 2018-2029
6.5.2 By Country – Europe Milbemycin Oxime Sales, 2018-2029
6.5.3 Germany Milbemycin Oxime Market Size, 2018-2029
6.5.4 France Milbemycin Oxime Market Size, 2018-2029
6.5.5 U.K. Milbemycin Oxime Market Size, 2018-2029
6.5.6 Italy Milbemycin Oxime Market Size, 2018-2029
6.5.7 Russia Milbemycin Oxime Market Size, 2018-2029
6.5.8 Nordic Countries Milbemycin Oxime Market Size, 2018-2029
6.5.9 Benelux Milbemycin Oxime Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Milbemycin Oxime Revenue, 2018-2029
6.6.2 By Region – Asia Milbemycin Oxime Sales, 2018-2029
6.6.3 China Milbemycin Oxime Market Size, 2018-2029
6.6.4 Japan Milbemycin Oxime Market Size, 2018-2029
6.6.5 South Korea Milbemycin Oxime Market Size, 2018-2029
6.6.6 Southeast Asia Milbemycin Oxime Market Size, 2018-2029
6.6.7 India Milbemycin Oxime Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Milbemycin Oxime Revenue, 2018-2029
6.7.2 By Country – South America Milbemycin Oxime Sales, 2018-2029
6.7.3 Brazil Milbemycin Oxime Market Size, 2018-2029
6.7.4 Argentina Milbemycin Oxime Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Milbemycin Oxime Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Milbemycin Oxime Sales, 2018-2029
6.8.3 Turkey Milbemycin Oxime Market Size, 2018-2029
6.8.4 Israel Milbemycin Oxime Market Size, 2018-2029
6.8.5 Saudi Arabia Milbemycin Oxime Market Size, 2018-2029
6.8.6 UAE Milbemycin Oxime Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Boehringer-Ingelheim
7.1.1 Boehringer-Ingelheim Company Summary
7.1.2 Boehringer-Ingelheim Business Overview
7.1.3 Boehringer-Ingelheim Milbemycin Oxime Major Product Offerings
7.1.4 Boehringer-Ingelheim Milbemycin Oxime Sales and Revenue in Global (2018-2023)
7.1.5 Boehringer-Ingelheim Key News & Latest Developments
7.2 Virbac
7.2.1 Virbac Company Summary
7.2.2 Virbac Business Overview
7.2.3 Virbac Milbemycin Oxime Major Product Offerings
7.2.4 Virbac Milbemycin Oxime Sales and Revenue in Global (2018-2023)
7.2.5 Virbac Key News & Latest Developments
7.3 Ceva
7.3.1 Ceva Company Summary
7.3.2 Ceva Business Overview
7.3.3 Ceva Milbemycin Oxime Major Product Offerings
7.3.4 Ceva Milbemycin Oxime Sales and Revenue in Global (2018-2023)
7.3.5 Ceva Key News & Latest Developments
7.4 Krka
7.4.1 Krka Company Summary
7.4.2 Krka Business Overview
7.4.3 Krka Milbemycin Oxime Major Product Offerings
7.4.4 Krka Milbemycin Oxime Sales and Revenue in Global (2018-2023)
7.4.5 Krka Key News & Latest Developments
7.5 Elanco
7.5.1 Elanco Company Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Milbemycin Oxime Major Product Offerings
7.5.4 Elanco Milbemycin Oxime Sales and Revenue in Global (2018-2023)
7.5.5 Elanco Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Milbemycin Oxime Major Product Offerings
7.6.4 Novartis Milbemycin Oxime Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Purina
7.7.1 Purina Company Summary
7.7.2 Purina Business Overview
7.7.3 Purina Milbemycin Oxime Major Product Offerings
7.7.4 Purina Milbemycin Oxime Sales and Revenue in Global (2018-2023)
7.7.5 Purina Key News & Latest Developments
8 Global Milbemycin Oxime Production Capacity, Analysis
8.1 Global Milbemycin Oxime Production Capacity, 2018-2029
8.2 Milbemycin Oxime Production Capacity of Key Manufacturers in Global Market
8.3 Global Milbemycin Oxime Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Milbemycin Oxime Supply Chain Analysis
10.1 Milbemycin Oxime Industry Value Chain
10.2 Milbemycin Oxime Upstream Market
10.3 Milbemycin Oxime Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Milbemycin Oxime Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Milbemycin Oxime in Global Market
Table 2. Top Milbemycin Oxime Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Milbemycin Oxime Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Milbemycin Oxime Revenue Share by Companies, 2018-2023
Table 5. Global Milbemycin Oxime Sales by Companies, (K Units), 2018-2023
Table 6. Global Milbemycin Oxime Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Milbemycin Oxime Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Milbemycin Oxime Product Type
Table 9. List of Global Tier 1 Milbemycin Oxime Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Milbemycin Oxime Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Dose – Global Milbemycin Oxime Revenue, (US$, Mn), 2022 & 2029
Table 12. By Dose - Global Milbemycin Oxime Revenue (US$, Mn), 2018-2023
Table 13. By Dose - Global Milbemycin Oxime Revenue (US$, Mn), 2024-2029
Table 14. By Dose - Global Milbemycin Oxime Sales (K Units), 2018-2023
Table 15. By Dose - Global Milbemycin Oxime Sales (K Units), 2024-2029
Table 16. By Application – Global Milbemycin Oxime Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Milbemycin Oxime Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Milbemycin Oxime Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Milbemycin Oxime Sales (K Units), 2018-2023
Table 20. By Application - Global Milbemycin Oxime Sales (K Units), 2024-2029
Table 21. By Region – Global Milbemycin Oxime Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Milbemycin Oxime Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Milbemycin Oxime Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Milbemycin Oxime Sales (K Units), 2018-2023
Table 25. By Region - Global Milbemycin Oxime Sales (K Units), 2024-2029
Table 26. By Country - North America Milbemycin Oxime Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Milbemycin Oxime Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Milbemycin Oxime Sales, (K Units), 2018-2023
Table 29. By Country - North America Milbemycin Oxime Sales, (K Units), 2024-2029
Table 30. By Country - Europe Milbemycin Oxime Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Milbemycin Oxime Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Milbemycin Oxime Sales, (K Units), 2018-2023
Table 33. By Country - Europe Milbemycin Oxime Sales, (K Units), 2024-2029
Table 34. By Region - Asia Milbemycin Oxime Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Milbemycin Oxime Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Milbemycin Oxime Sales, (K Units), 2018-2023
Table 37. By Region - Asia Milbemycin Oxime Sales, (K Units), 2024-2029
Table 38. By Country - South America Milbemycin Oxime Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Milbemycin Oxime Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Milbemycin Oxime Sales, (K Units), 2018-2023
Table 41. By Country - South America Milbemycin Oxime Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Milbemycin Oxime Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Milbemycin Oxime Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Milbemycin Oxime Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Milbemycin Oxime Sales, (K Units), 2024-2029
Table 46. Boehringer-Ingelheim Company Summary
Table 47. Boehringer-Ingelheim Milbemycin Oxime Product Offerings
Table 48. Boehringer-Ingelheim Milbemycin Oxime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Boehringer-Ingelheim Key News & Latest Developments
Table 50. Virbac Company Summary
Table 51. Virbac Milbemycin Oxime Product Offerings
Table 52. Virbac Milbemycin Oxime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Virbac Key News & Latest Developments
Table 54. Ceva Company Summary
Table 55. Ceva Milbemycin Oxime Product Offerings
Table 56. Ceva Milbemycin Oxime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Ceva Key News & Latest Developments
Table 58. Krka Company Summary
Table 59. Krka Milbemycin Oxime Product Offerings
Table 60. Krka Milbemycin Oxime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Krka Key News & Latest Developments
Table 62. Elanco Company Summary
Table 63. Elanco Milbemycin Oxime Product Offerings
Table 64. Elanco Milbemycin Oxime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Elanco Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Milbemycin Oxime Product Offerings
Table 68. Novartis Milbemycin Oxime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Purina Company Summary
Table 71. Purina Milbemycin Oxime Product Offerings
Table 72. Purina Milbemycin Oxime Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Purina Key News & Latest Developments
Table 74. Milbemycin Oxime Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Milbemycin Oxime Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Milbemycin Oxime Production by Region, 2018-2023 (K Units)
Table 77. Global Milbemycin Oxime Production by Region, 2024-2029 (K Units)
Table 78. Milbemycin Oxime Market Opportunities & Trends in Global Market
Table 79. Milbemycin Oxime Market Drivers in Global Market
Table 80. Milbemycin Oxime Market Restraints in Global Market
Table 81. Milbemycin Oxime Raw Materials
Table 82. Milbemycin Oxime Raw Materials Suppliers in Global Market
Table 83. Typical Milbemycin Oxime Downstream
Table 84. Milbemycin Oxime Downstream Clients in Global Market
Table 85. Milbemycin Oxime Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Milbemycin Oxime Segment by Dose in 2022
Figure 2. Milbemycin Oxime Segment by Application in 2022
Figure 3. Global Milbemycin Oxime Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Milbemycin Oxime Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Milbemycin Oxime Revenue, 2018-2029 (US$, Mn)
Figure 7. Milbemycin Oxime Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Milbemycin Oxime Revenue in 2022
Figure 9. By Dose - Global Milbemycin Oxime Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Dose - Global Milbemycin Oxime Revenue Market Share, 2018-2029
Figure 11. By Dose - Global Milbemycin Oxime Sales Market Share, 2018-2029
Figure 12. By Dose - Global Milbemycin Oxime Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Milbemycin Oxime Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Milbemycin Oxime Revenue Market Share, 2018-2029
Figure 15. By Application - Global Milbemycin Oxime Sales Market Share, 2018-2029
Figure 16. By Application - Global Milbemycin Oxime Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Milbemycin Oxime Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Milbemycin Oxime Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Milbemycin Oxime Revenue Market Share, 2018-2029
Figure 20. By Region - Global Milbemycin Oxime Sales Market Share, 2018-2029
Figure 21. By Country - North America Milbemycin Oxime Revenue Market Share, 2018-2029
Figure 22. By Country - North America Milbemycin Oxime Sales Market Share, 2018-2029
Figure 23. US Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Milbemycin Oxime Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Milbemycin Oxime Sales Market Share, 2018-2029
Figure 28. Germany Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 29. France Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Milbemycin Oxime Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Milbemycin Oxime Sales Market Share, 2018-2029
Figure 37. China Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 41. India Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Milbemycin Oxime Revenue Market Share, 2018-2029
Figure 43. By Country - South America Milbemycin Oxime Sales Market Share, 2018-2029
Figure 44. Brazil Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Milbemycin Oxime Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Milbemycin Oxime Sales Market Share, 2018-2029
Figure 48. Turkey Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Milbemycin Oxime Revenue, (US$, Mn), 2018-2029
Figure 52. Global Milbemycin Oxime Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Milbemycin Oxime by Region, 2022 VS 2029
Figure 54. Milbemycin Oxime Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ミルベマイシンオキシムの世界市場見通し2023年-2029年(Milbemycin Oxime Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ミルベマイシンオキシムの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp